4841 - 4850 of 7665 Results
Title
Year
-
RESTRICTEDTitle: Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progressionJournal Name: eBioMedicinePublisher: Elsevier BVVol: 44Issue #:Start Page: 691End Page: 707Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2019.05.064Best OA location URL: http://www.thelancet.com/article/S235239641930372X/pdfCitation Count: 234
-
RESTRICTEDTitle: Illuminating G-Protein-Coupling Selectivity of GPCRsJournal Name: CellPublisher: Elsevier BVVol: 177Issue #: 7Start Page: 1933End Page: 1947.e25Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2019.04.044Best OA location URL: http://www.cell.com/article/S0092867419304969/pdfCitation Count: 413
- M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder2019RESTRICTEDTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://europepmc.org/articles/pmc6555658?pdf=renderCitation Count: 27
-
RESTRICTEDTitle: Management of Dysphagia in Acquired and Progressive Neurologic ConditionsJournal Name: Seminars in Speech and LanguagePublisher: Georg Thieme Verlag KGVol: 40Issue #: 03Start Page: 203End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0039-1688981Best OA location URL: https://europepmc.org/articles/pmc7253010?pdf=renderCitation Count: 2
- OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial2019RESTRICTEDTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/records/3832127/files/R1-OnabotulinumtoxinA_and_Cognitive_Behavioral_Therapy_in_Functional_Dystonia_A_Pilot_Randomized_Clinical_Trial_pdf.io.pdfCitation Count: 13
-
RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 5
- End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers2019RESTRICTEDTitle: End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregiversJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 5Start Page: e0217039End Page: e0217039Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0217039Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0217039&type=printableCitation Count: 23
- Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases2019RESTRICTEDTitle: Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseasesJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1315End Page: 1324Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27728Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27728Citation Count: 31
-
RESTRICTEDTitle: The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegenerationJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 7Start Page: 959End Page: 969Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27718Best OA location URL: https://europepmc.org/articles/pmc6642014?pdf=renderCitation Count: 69
-
RESTRICTEDTitle: Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 9Issue #: 2Start Page: 301End Page: 313Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191576Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191576?id=journal-of-parkinsons-disease%2Fjpd191576Citation Count: 96